title: Cytochrome P450 2D6 polymorphism and its impact on decision-making in psychopharmacotherapy: finding the right way in an ultrarapid metabolizing patient.
authors: Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, and JARA—Translational Brain Medicine, Aachen, Germany. mpaulzen@ukaachen.de
authors: Michael
authors: M
authors: Paulzen
authors: Simone C
authors: SC
authors: Tauber
authors: André
authors: A
authors: Kirner-Veselinovic
authors: Gerhard
authors: G
authors: Gründer
mesh_terms: D000928:Antidepressive Agents / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D016903:Drug Monitoring; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D019389:Cytochrome P-450 CYP2D6